Nanotechnology firm Liquidia partners with PATH on new pneumonia vaccine
• MEDCityNorth Carolina nanotechnology company Liquidia Technologies is partnering with nonprofit organization PATH to develop a new pneumonia vaccine that could be deployed globally.